Cefacetrile
WikiDoc Resources for Cefacetrile |
Articles |
---|
Most recent articles on Cefacetrile Most cited articles on Cefacetrile |
Media |
Powerpoint slides on Cefacetrile |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cefacetrile at Clinical Trials.gov Clinical Trials on Cefacetrile at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cefacetrile
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cefacetrile Discussion groups on Cefacetrile Patient Handouts on Cefacetrile Directions to Hospitals Treating Cefacetrile Risk calculators and risk factors for Cefacetrile
|
Healthcare Provider Resources |
Causes & Risk Factors for Cefacetrile |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cefacetrile (INN, also spelled cephacetrile) is a broad-spectrum first generation cephalosporin antibiotic effective in gram-positive and gram-negative bacterial infections. It is a bacteriostatic antibiotic.[1][2] Cefacetrile is marketed under the trade names Celospor, Celtol, and Cristacef,[3] and as Vetimast for the treatment of mammary infections in lactating cows.[2]
References
- ↑ "Cefacetrile Summary Report" (PDF). European Medicines Agency, Committee for Veterinary Medicinal Products. 1998.
- ↑ 2.0 2.1 Haberfeld, H, ed. (2007). Austria-Codex (in German) (2007/2008 ed.). Vienna: Österreichischer Apothekerverlag. ISBN 3-85200-183-8.
- ↑ PMID 7206219 (PMID 7206219)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand